PREVIOUS
✖
Favipiravir trial in India
May 13 , 2020
1660 days
853
0
- The Council of Scientific and Industrial Research (CSIR) begins its clinical trials on Favipiravir and Phyto pharmaceutical.
- Favipiravir is commonly used in China and Japan and also in other countries to treat influenza.
- The CSIR is also working on native herbs as biological medicine.
- The DGCI (Drug Controller General of India) has approved the clinical trials.
Leave a Reply
Your Comment is awaiting moderation.